{
  "id": 2706,
  "origin_website": "Cell",
  "title": "Specific and efficient gene knockout and overexpression in mouse interscapular brown adipocytes in vivo",
  "procedures": [
    "Step-by-step method details\nStep-by-step method details\nScreen efficient sgRNAs in mouse melanoma cells using pAAV-sgRNA vector\nTiming: 10 days\nThe sgRNAs targeting mouse genes with editing efficiency are screened using lentiCRISPRv2 vector transfected in mouse melanoma cells.\nPrepare lentiCRISPRv2-sgRNA vector.\nAnneal the sgRNA oligonucleotides as inserts.\nAnneal each pair of sgRNA oligonucleotides as the following reaction.\ntable:files/protocols_protocol_2195_5.csv\nAnneal in a thermocycler at 37°C for 30 min, then 95°C for 5 min and ramp down to 25°C (5°C/min).\nDigest 2 μg of lentiCRISPRv2 plasmid at 55°C for 40 min and purify the digested plasmids from the 0.8% agarose gel using Thermo Scientific GeneJET Gel Extraction Kit (K0691) following the manufacturer’s instructions. (https://www.thermofisher.cn/document-connect/document-connect.html?url=https://assets.thermofisher.cn/TFS-Assets%2FLSG%2Fmanuals%2FMAN0012661_GeneJET_Gel_Extraction_UG.pdf[href=https://www.thermofisher.cn/document-connect/document-connect.html?url=https://assets.thermofisher.cn/TFS-Assets%2FLSG%2Fmanuals%2FMAN0012661_GeneJET_Gel_Extraction_UG.pdf]).\ntable:files/protocols_protocol_2195_6.csv\nClone the annealed oligos into the digested lentiCRISPRv2 vector.\nDilute the annealed oligos at 1:10.\nSet up the ligation reaction as follows and incubate the reaction at 25°C for 2 h.\ntable:files/protocols_protocol_2195_7.csv\nTransform the ligation mixture into Stbl3 competent cells. Transform 2 μL of each ligation mixture into 50 μL of Stbl3 competent cells and incubate the mixture for 20 min on ice. After heat shock at 42°C for 90 s, the transformation mixture is immediately incubated on ice for 2 min. Then, add 200 μL of LB medium to the mixture and allow the transformed cells to recover at 37°C for 1 h with 220 rpm shaking.\nAdd the transformed cells onto the LB plate with 100 mg/mL ampicillin and incubate the LB plate at 37°C for 14 h to allowing colonies to grow.\nPick 2 colonies from each lentiCRISPRv2-sgRNA plate into 5 mL LB medium with 100 mg/mL ampicillin to be incubated at 37°C with 220 rpm shaking for 8–10 h and perform plasmid miniprep using Thermo Scientific GeneJET Plasmid Miniprep Kit (K0502) following the manufacturer’s instructions (https://www.thermofisher.cn/document-connect/document-connect.html?url=https://assets.thermofisher.cn/TFS-Assets%2FLSG%2Fmanuals%2FMAN0012655_GeneJET_Plasmid_Miniprep_UG.pdf[href=https://www.thermofisher.cn/document-connect/document-connect.html?url=https://assets.thermofisher.cn/TFS-Assets%2FLSG%2Fmanuals%2FMAN0012655_GeneJET_Plasmid_Miniprep_UG.pdf]).",
    "Sequence each colony to confirm the sgRNA insertion into lentiCRISPRv2 vector.\nScreen sgRNAs with editing efficiency in mouse melanoma cells (troubleshooting 1[href=https://www.wicell.org#sec6.1]) (troubleshooting 2[href=https://www.wicell.org#sec6.3]).\nMouse melanoma cells (B16F10) are cultured in DMEM supplemented with 10% FBS at 37°C in a 5% CO2 incubator.\nPlate B16F10 cells onto 12-well plate in DMEM supplemented with 10% FBS.\nWhen cells reach 80%–90% confluent, transfect 1 μg of lentiCRISPRv2-sgRNA plasmid into each well using PEI as follows. Preheat PEI solution and DMEM at 37°C and prepare plasmid/DMEM mixture for each well of cells. Add 3 μL of PEI into the plasmid/DMEM mixture (the ratio of PEI (μL): plasmid (μg) is 3:1), mix well, and place at room temperature for 10 min. Add the transfection mixture into each well of B16F10 cells.\ntable:files/protocols_protocol_2195_8.csv\nNote: Each lentiCRISPRv2-sgRNA plasmid is transfected in 2 wells, one for genomic DNA sequencing and another one for western blot analysis.\nCritical: The control sgRNA targets a gene not existing in the mouse genome (LacZ here).\n24 h after transfection, pass the B16F10 cells from the 12-well plate onto the 6-well plate. Culture one well of cells in 2 mL of DMEM supplemented with 10% FBS and 10 μM puromycin for 48–60 h to remove non-infected dead cells.\nWash cells with PBS buffer to remove the dead cells and collect the remaining cells for genomic DNA extraction.\nGenomic DNA is extracted using Invitrogen Purelink Genomic DNA Kit (K182001) following the manufacturer’s instructions (https://www.thermofisher.cn/document-connect/document-connect.html?url=https://assets.thermofisher.cn/TFS-Assets%2FLSG%2Fmanuals%2Fpurelink_genomic_man.pdf[href=https://www.thermofisher.cn/document-connect/document-connect.html?url=https://assets.thermofisher.cn/TFS-Assets%2FLSG%2Fmanuals%2Fpurelink_genomic_man.pdf]).\nAmplify the sgRNA target region on genomic DNA via PCR using a pair of PCR primers (Seq-F/R primers) to produce 400–600 bp amplicons with the sgRNA target sequence in the center. Set up the PCR reaction as follows.\ntable:files/protocols_protocol_2195_9.csv\nThen run PCR using the following cycling condition.\ntable:files/protocols_protocol_2195_10.csv",
    "Purify the PCR products from the 2% agarose gel using Thermo Scientific GeneJET Gel Extraction Kit (K0691).\nSequence the amplicons of control sgRNA and target gene sgRNA samples using Seq-F primer.\nAnalyze the editing efficiency through uploading sgRNA sequence and sequencing results of control and experimental amplicons onto the software ICE (https://ice.synthego.com/#/[href=https://ice.synthego.com/]).\nSelect at least two sgRNAs with the highest editing activity based on the Indel %, Model Fit and Knockout-Score got from ICE analyses (Figure 2[href=https://www.wicell.org#fig2]).\nimgsrc:https://prod-shared-star-protocols.s3.amazonaws.com/protocols/2195-Fig2.jpg\nFigure 2. Analysis of the editing efficiency of the sgRNAs by sequencing the amplicons of sgRNA-targeted region on genomic DNA\n(A) The disorderly sequencing peaks suggest potential editing activity of Emre-sgRNAs compared to control-sgRNA.\n(B) The editing efficiency analyzed by the ICE software.\nAnother well of transfected cells is used for protein extraction to confirm the knock-out efficiency of the target gene on protein level by western blot.\npAAV-sgRNA-mCherry vector construction.\nsgRNA synthesis. Select two sgRNAs with highest editing efficiency verified in step 2 and synthesize the oligonucleotides as follows. sgRNA-F: 5′-ACCGNNNNNNNNNNNNNNNNNNNN-3′. sgRNA-R: 5′-AACANNNNNNNNNNNNNNNNNNNNC-3′.\nAnneal the sgRNA oligos as inserts.\nDigest 2 μg of pAAV-U6-gRNA-CBh-mCherry plasmid with BspQI at 50°C for 40 min.\ntable:files/protocols_protocol_2195_11.csv\nPurify the digested plasmids from the 0.8% agarose gel using Thermo Scientific GeneJET Gel Extraction Kit (K0691).\nLigate the annealed oligos into the digested pAAV-U6-gRNA-CBh-mCherry plasmid.\nDilute the annealed oligos at 1:10.\nSet up the ligation reaction as follows and incubate the reaction at 25°C for 2 h.\ntable:files/protocols_protocol_2195_12.csv\nTransform the ligation mixture into T1 competent cells. Transform 2 μL of the ligation mixture into 50 μL of T1 competent cells and incubate the mixture for 20 min on ice. After heat shock at 42°C for 90 s, the transformation mixture is immediately incubated on ice for 2 min.",
    "Plate transformed cells onto the LB plate with 100 mg/mL ampicillin and incubate the LB plate at 37°C for 14 h allowing colonies to grow.\nPick 2 colonies from each pAAV-U6-gRNA-CBh-mCherry plate into 5 mL LB medium with 100 mg/mL ampicillin to be incubated at 37°C with 220 rpm shaking for 8–10 h and perform plasmid miniprep.\nSequence each colony to confirm the sgRNA insertions into the pAAV-U6-gRNA-mCherry vector.\nDesign sgRNA-resistant cDNA of target gene and construct AAV vector\nTiming: 6 days\nTo avoid recognition by sgRNA-CRISPR, sgRNA-resistant cDNA of the target gene is designed by the introduction of synonymous mutations on the critical “GG” in the PAM motif (NGG) and on the sgRNA-targeted sequence region. Using sgRNA-resistant cDNA, we can rescue with tagged wild-type or mutant protein according to experimental purpose in the knockout context of the endogenous gene.\nConstruct pAAV-ADP (adiponectin promoter)-EMRE-FLAG (troubleshooting 4[href=https://www.wicell.org#sec6.5]).\nUse SLIC (sequence and ligation-independent cloning) to insert EMRE-cDNA into the MCS (multiclonal site) of pAAV-ADP-MCS-FLAG. Design SLIC PCR primers according to the selected dual enzyme cleavage sites in the MCS of pAAV-ADP-MCS-FLAG.\nimgsrc:https://prod-shared-star-protocols.s3.amazonaws.com/protocols/2195-Fig3.jpg\nFigure 3. Design SLIC PCR primers to clone EMRE-cDNA into pAAV-ADP-MCS-3×FLAG\nNote: In this case we select AgeΙ and SalI as dual enzyme cleavage sites, and synthesize the SLIC PCR primers as shown in Figure 3[href=https://www.wicell.org#fig3].\nUse the above SLIC PCR primers to amplify the EMRE insert. Perform PCR using Vazyme Phanta Max Super-Fidelity DNA Polymerase kit (P505d1) and set up PCR reaction as below.\ntable:files/protocols_protocol_2195_13.csv\nRun PCR using the following cycling condition.\ntable:files/protocols_protocol_2195_14.csv\nPurify the PCR amplicons as SLIC inserts using Thermo Scientific GeneJET Gel Extraction Kit (K0691).\nDigest 2 μg of pAAV-ADP-MCS-FLAG plasmid with AgeI and SalI at 37°C for 60 min as below.\ntable:files/protocols_protocol_2195_15.csv",
    "Purify the digested plasmid as the SLIC vector using Thermo Scientific GeneJET Gel Extraction Kit (K0691).\nPerform SLIC reaction to construct pAAV-ADP-EMRE-3×FLAG.\nSet up SLIC reaction as below.\ntable:files/protocols_protocol_2195_16.csv\nPlace the reaction tube on ice for 5 min and the following steps should be performed on ice.\nAdd 0.25 μL Exonuclease III (40 units) to the tube and mix well by pipetting for several times, and then place on ice for 30 min.\nAdd 0.5 μL 0.5 M EDTA (pH 8.0) into the tube and mix by pipetting for several times, and then incubate the mixture at 65°C for 5 min to stop the reaction.\nCentrifuge the tube to concentrate the mixture.\nReplace the reaction tube on ice to cool down for 5 min.\nTransform the total reaction mixture into 50 μL T1 competent cells and incubate the mixture for 20 min on ice. After heat shock at 42°C for 90 s, the mixture is immediately incubated on ice for 2 min.\nPlate transformed cells onto the LB plate with 100 mg/mL ampicillin and incubate the LB plate at 37°C for 14 h allowing colonies to grow.\nPick 2 colonies from the plate into 5 mL LB medium with 100 mg/mL ampicillin to be incubated at 37°C with 220 rpm shaking for 8–10 h and perform plasmid miniprep.\nSequence each colony to confirm the correct construction of pAAV-ADP-EMRE-3×FLAG.\nDesign synonymously mutagenic primers for sgRNA-resistant cDNA of target gene (troubleshooting 2[href=https://www.wicell.org#sec6.3]).\nSynonymously mutate the “GG” in the PAM motif (NGG) which is critical for the recognition by sgRNA-spCas9.\nNote: In this case, since synonymous mutations cannot be performed on the “GG”, we mutate the glycine containing “GG” to serine in smdt1 of homo sapiens, as illustrated in Figure 4[href=https://www.wicell.org#fig4].\nSynonymously mutate the sgRNA-targeting sequence as illustrated in Figure 4[href=https://www.wicell.org#fig4].\nimgsrc:https://prod-shared-star-protocols.s3.amazonaws.com/protocols/2195-Fig4.jpg",
    "Figure 4. Design synonymously mutagenic primers for sgRNA-resistant cDNA of target gene\nDesign and synthesize the synonymously mutagenic primers as follows. sgRNA-resis-mutation-F: 5′-GGGGAGGAGAGGTGGAGACGTGTATACGGTTCCCTCCAGCTCAGG-3′. sgRNA-resis-mutation-R: 5′-CTGAGACCTGAGCTGGAGGGAACCGTATACACGTCTCCACCTCTC-3′.\nTake pAAV-ADP-EMRE-3×FLAG plasmid as PCR template and use synonymously mutagenic primers to produce sgRNA-resistant pAAV-ADP-EMRE-resis-3×FLAG.\nSet up PCR reaction as follows to perform site-directed mutagenesis using Vazyme Phanta Max Super-Fidelity DNA Polymerase kit.\ntable:files/protocols_protocol_2195_17.csv\nRun PCR using the following cycling condition.\ntable:files/protocols_protocol_2195_18.csv\nAdd 0.5 μL of 10 μM sgRNA-resis-mutant-R to the PCR reaction mixture and run PCR using the following cycling condition.\ntable:files/protocols_protocol_2195_19.csv\nDigest the PCR amplicons with DpnI at 37°C for 2 h to remove the template plasmid as follows.\ntable:files/protocols_protocol_2195_20.csv\nAdd 5 μL of the digestion mixture into 50 μL T1 competent cells and incubate the mixture on ice for 20 min. After heat shock at 42°C for 90 s, the mixture is immediately incubated on ice for 2 min.\nPlate the transformed cells onto LB plate with 100 mg/mL ampicillin and incubate the LB plate at 37°C for 14 h allowing colonies to grow.\nPick 2 colonies from the plate into 5 mL LB medium with 100 mg/mL ampicillin to be incubated at 37°C with 220 rpm shaking for 8–10 h and perform plasmid miniprep.\nSequence each colony to confirm the correct mutation of pAAV-ADP-EMRE-resis-3×FLAG.\nUse SLIC to insert EMRE-resis-cDNA into the MCS of pAAV-ADP-MCS-3×FLAG via SLIC-EMRE-F/R primers to avoid vector mutation, following step 4.\nAAV production\nTiming: 1 week\nIn this protocol, we use AAV8 serotype that can effectively infect BAT.12[href=https://www.wicell.org#bib12] AAV-U6-Emre-sgRNA-mCherry, AAV-U6-Ctrl-sgRNA-mCherry and AAV-ADP-EMRE-resis-3×FLAG are produced following the previous step-by-step instructions.13[href=https://www.wicell.org#bib13] The AAV titer for the following AAV injection experiments should be above 1 × 1013 vg/mL (vector genomes per mL).\nLocal injection of AAV into intrascapular BAT (iBAT)\nTiming: 3 weeks\nPreparation for local injection of AAV.",
    "Prepare surgical equipment as in key resources table[href=https://www.wicell.org#key-resources-table].\nNote: all the surgical equipment should be sterilized with 75% ethanol before surgical operation.\nSet up injection device.\nConnect the tail end of a pen needle to a polyethylene tubing (5 cm in length), as illustrated in Figures 5[href=https://www.wicell.org#fig5]A and 5B.\nimgsrc:https://prod-shared-star-protocols.s3.amazonaws.com/protocols/2195-Fig5.jpg\nFigure 5. Set up injection device\n(A) 33G needle for pen injectors.\n(B) Connect the tail end of a pen needle to a polyethylene tubing.\n(C) The injection device assembled by connecting a needle of microsyringe (50 μL) to the other side of the polyethylene tubing.\nConnect a needle of microsyringe (50 μL) to the other side of the polyethylene tubing, as illustrated in Figure 5[href=https://www.wicell.org#fig5]C.\nTest the assembled injection device and make sure all the connections are sealed well without leakage.\nPrepare virus solution (troubleshooting 5[href=https://www.wicell.org#sec6.9]).\nDilute AAVs with PBS as follows to achieve the volume for injection (50 μL for each lobe of iBAT, 100 μL for each mouse).\ntable:files/protocols_protocol_2195_21.csv\nDraw 50 μL of virus solution with microsyringe and connect the injection device.\nSurgical operation for local injection of AAV into iBAT (troubleshooting 3[href=https://www.wicell.org#sec6.5]) (Methods video S1[href=https://www.wicell.org#mmc1]).\nAnaesthetize mice with 2,2,2-Tribromoethanol. Inject mice with 2,2,2-Tribromoethanol working solution (20 μL/g body weight) through intraperitoneal injection. Two min after injection, the mice will be anaesthetized deeply enough to perform surgical operation.\nNote: The anaesthetized mice should be on a heating pad during all the surgical process.\nRemove the hair above iBAT using an animal hair clipper and wipe the exposed skin with ethanol (Figure 6[href=https://www.wicell.org#fig6]A).\nimgsrc:https://prod-shared-star-protocols.s3.amazonaws.com/protocols/2195-Fig6.jpg\nFigure 6. Surgical operation for local injection of AAV into iBAT\n(A) Remove the hair above iBAT to exposure the skin.\n(B) Cut a 0.5–0.8 cm incision in the skin above iBAT as indicated by the red dotted line.",
    "(C) The left lobe of iBAT illustrated as the red dotted circle.\n(D) The right lobe of iBAT illustrated as the red dotted circle.\n(E) Insert the pen needle into the fat pad of iBAT, and the injection point is indicated by the red arrow.\n(F) Close the incision with two surgical suture clips (9 mm) as indicated by the red arrows.\nCut a 0.5–0.8 cm incision in the skin above iBAT with a surgical scissor to expose the two lobes of iBAT (Figures 6[href=https://www.wicell.org#fig6]B–6D).\nHold the injection device and carefully insert the pen needle into the fat pad of one iBAT lobe, as illustrated in Figure 6[href=https://www.wicell.org#fig6]E. When the needle is inserted well, inject 5 μL virus for one point and inject 10 points (50 μL virus) to distribute evenly throughout one lobe of iBAT.\nCritical: The depth of needle insertion should be 1–2 mm avoiding too deep or too superficial.\nDraw another 50 μL of virus solution rapidly for another lobe of iBAT.\nAfter injection, close the incision with two surgical suture clips (9 mm) (Figure 6[href=https://www.wicell.org#fig6]F).\nNote: The suture clips should be clamped tightly using a clip applicator avoiding shedding.\nInject mice with analgesic (Tolfedine, 2 mg/kg body weight) by a single intramuscular injection.\nKeep the mice on a heating pad until revivtication.\nPlace one mouse per cage to avoid fighting. Monitor the health status of mice daily and inject the mice with analgesic (Tolfedine, 2 mg/kg body weight) at 24 h and 48 h after the surgery.\nNote: Recovery time after surgery is about 7 days. It needs 3 weeks after AAV injection to allow sufficient CRISPR editing in vivo and enough overexpression of protein driven by adiponectin promoter.\n    Your browser does not support HTML5 video.",
    "Methods video S1. Surgical operation for local injection of AAV into iBAT, related to step 8\nKnockout and rescue efficiency detection\nTiming: 2 days\nIsolation of BAT mitochondria.\nIsolate the iBAT from mice injected with AAV for 3 weeks and immediately transfer the iBAT into 2 mL tube with 0.5 mL BAT mitochondrion isolation buffer.\nNote: The whole isolation process should be performed on ice. The buffer and equipment used for mitochondrion isolation should be precooled on ice.\nMince the iBAT into small pieces (1 mm3 each) with a scissor in 2-mL tube and transfer the content into a Teflon-glass Dounce homogenizer (Wheaton, 2 mL). Wash the tube with 0.5 mL isolation buffer and collect it into the homogenizer (total 1 mL content in the homogenizer).\nHomogenize the iBAT pieces with a teflon pestle for 10 strokes. Transfer the homogenate into a new 2 mL tube and wash the homogenizer with 0.5 mL isolation buffer and collect it into the 2 mL tube (total 1.5 mL homogenate in the tube).\nCentrifuge at 8,500 g for 10 min to separate the lipids from the cell lysate in brown adipocytes.\nAfter centrifugation, discard the upper lipid layer and the supernatant, and keep the pellet.\nResuspend the pellet with 0.5 mL isolation buffer and transfer it into homogenizer. Wash the tube with 0.5 mL isolation buffer and collect it into the homogenizer (total 1 mL content in the homogenizer).\nHomogenize the resuspended pellet with a teflon pestle for 5–8 strokes and transfer the homogenate into a new 2 mL tube. Wash the homogenizer with 0.5 mL isolation buffer and collect it into the 2 mL tube (total 1.5 mL homogenate in the tube).\nCentrifuge at 700 g for 10 min to separate mitochondria from other cell components.",
    "Transfer the supernatant containing mitochondria to a new 2 mL tube and centrifuge at 8,500 g for 10 min to precipitate the mitochondria.\nDiscard the supernatant and dissolve the mitochondrion pellet with 1% digitonin buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1 mM EDTA and 1× complete protease inhibitor.\nAfter dissolution on ice for 30 min, centrifuge at 20,000 g for 10 min at 4°C, and the supernatant (mitochondrial protein lysate) can be used to detect the knockout and rescue efficiency by western blot."
  ],
  "subjectAreas": [
    "Molecular Biology",
    "Metabolism",
    "Model Organisms",
    "Crispr"
  ],
  "bigAreas": [
    "Molecular Biology & Genetics"
  ]
}